Plasma phospholipid saturated fatty acids and heart failure risk in the physicians' health study

Clinical Nutrition

Volumn 32, Issue 5, 2013, Pages 819-823

  Matsumoto, Chisa ^a,b   Hanson, Naomi Q ^d   Tsai, Michael Y ^d   Glynn, Robert J ^a,b   Gaziano, J Michael ^a,b,c   Djoussé, Luc ^a,b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Heart failure; Palmitic acid; Saturated fatty acids

Indexed keywords

PALMITIC ACID; SATURATED FATTY ACID;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; GAS CHROMATOGRAPHY; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PHOSPHOLIPID BLOOD LEVEL; PHYSICIAN ATTITUDE; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; VALIDATION PROCESS;

HEART FAILURE; PALMITIC ACID; SATURATED FATTY ACIDS;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; DOUBLE-BLIND METHOD; FATTY ACIDS; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MEDICAL RECORDS; MIDDLE AGED; PALMITIC ACID; PHOSPHOLIPIDS; PHYSICIANS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; UNITED STATES;

EID: 84883551659     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.02.006     Document Type: Article

References (17)

1. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., et al. Heart disease and stroke statistics-2007 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 2007 Feb 6, 115(5):e69-e171.
2. Shafazand M., Rosengren A., Lappas G., Swedberg K., Schaufelberger M. Decreasing trends in the incidence of heart failure after acute myocardial infarction from 1993-2004: a study of 175,216 patients with a first acute myocardial infarction in Sweden. Eur J Heart Fail 2011 Feb, 13(2):135-141.
3. Ezekowitz J.A., Kaul P., Bakal J.A., Quan H., McAlister F.A. Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?. Eur J Heart Fail 2011 Feb, 13(2):142-147.
4. Simon J.A., Hodgkins M.L., Browner W.S., Neuhaus J.M., Bernert J.T., Hulley S.B. Serum fatty acids and the risk of coronary heart disease. Am J Epidemiol 1995 Sep 1, 142(5):469-476.
5. Zheng Z.J., Folsom A.R., Ma J., Arnett D.K., McGovern P.G., Eckfeldt J.H. Plasma fatty acid composition and 6-year incidence of hypertension in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1999 Sep 1, 150(5):492-500.
6. Ardehali H., Sabbah H.N., Burke M.A., Sarma S., Liu P.P., Cleland J.G., et al. Targeting myocardial substrate metabolism in heart failure: potential for new therapies. Eur J Heart Fail 2012 Feb, 14(2):120-129.
7. Galvao T.F., Brown B.H., Hecker P.A., O'Connell K.A., O'Shea K.M., Sabbah H.N., et al. High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects. Cardiovasc Res 2012 Jan 1, 93(1):24-32.
8. Chess D.J., Lei B., Hoit B.D., Azimzadeh A.M., Stanley W.C. Effects of a high saturated fat diet on cardiac hypertrophy and dysfunction in response to pressure overload. JCard Fail 2008 Feb, 14(1):82-88.
9. Volek J.S., Fernandez M.L., Feinman R.D., Phinney S.D. Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog Lipid Res 2008 Sep, 47(5):307-318.
10. Chiu H.C., Kovacs A., Ford D.A., Hsu F.F., Garcia R., Herrero P., et al. Anovel mouse model of lipotoxic cardiomyopathy. JClin Invest 2001 Apr, 107(7):813-822.
11. Final report on the aspirin component of the ongoing physicians' health study. NEngl J Med 1989 Jul 20, 321(3):129-135. Steering Committee of the Physicians' Health Study Research Group.
12. Christen W.G., Gaziano J.M., Hennekens C.H. Design of physicians' health study II-a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol 2000 Feb, 10(2):125-134.
13. Cao J., Schwichtenberg K.A., Hanson N.Q., Tsai M.Y. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006 Dec, 52(12):2265-2272.
14. Djousse L., Weir N.L., Hanson N.Q., Tsai M.Y., Gaziano J.M. Plasma phospholipid concentration of cis-palmitoleic acid and risk of heart failure. Circ Heart Fail 2012 Nov, 5(6):703-709.
15. Djousse L., Driver J.A., Gaziano J.M. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAm Med Assoc 2009 Jul 22, 302(4):394-400.
16. Yamagishi K., Nettleton J.A., Folsom A.R. Plasma fatty acid composition and incident heart failure in middle-aged adults: the atherosclerosis risk in communities (ARIC) study. Am Heart J 2008 Nov, 156(5):965-974.
17. Yamagishi K., Iso H., Yatsuya H., Tanabe N., Date C., Kikuchi S., et al. Dietary intake of saturated fatty acids and mortality from cardiovascular disease in Japanese: the Japan collaborative cohort study for evaluation of cancer risk (JACC) Study. Am J Clin Nutr 2010 Oct, 92(4):759-765.